Shares of Thermo Fisher Scientific (TMO) rose Thursday after the medical device maker's fourth-quarter results topped analysts' estimates.
Thermo Fisher reported revenue of $11.4 billion, up about 5% year-over-year and better than the $11.28 billion Visible Alpha consensus. Profit narrowly beat estimates at $1.83 billion, or $4.78 per share, up from $4.20 a year ago. Adjusted earnings per share (EPS) of $6.10 also topped expectations.
Sales increased across all four of the company's divisions, with revenue at its largest segment, Laboratory Products and Biopharma Services, rising 4%. Last quarter, shares fell as sales were flat or declined in two segments.
Thermo Fisher shares were up 6.6% intraday after entering Thursday roughly flat over the prior 12 months.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.